エディットフォース
2 known investors
EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries. The company aims to advance therapeutic drug development and address challenges in health, food, and environmental sectors.
AI & Machine LearningBiotech